Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Ki-67 and Bax expression in esophageal mucosa might have implications in ablative therapies for Barrett’s esophagus, dysplasia, and adenocarcinoma

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Lewis CJ, Thrumurthy SG, Pritchard S, Armstrong G, Attwood SE (2011) Comparison of COX-2, Ki-67, and BCL-2 expression in normal esophageal mucosa, Barrett’s esophagus, dysplasia, and adenocarcinoma with postablation mucosa and implications for ablative therapies. Surg Endosc 25:2564–2569

  2. 2.

    Pera M, Manterola C, Vidal O, Grande L (2005) Epidemiology of esophageal adenocarcinoma. J Surg Oncol 92:151–159

  3. 3.

    Voutilainen ME, Juhola MT (2005) The changing epidemiology of esophageal cancer in Finland and the impact of the surveillance of Barrett’s esophagus in detecting esophageal adenocarcinoma. Dis Esophagus 18:221–225

  4. 4.

    Garidou A, Tzonou A, Lipworth L, Signorello LB, Kalapothaki V, Trichopoulos D (1996) Life-style factors and medical conditions in relation to esophageal cancer by histologic type in a low-risk population. Int J Cancer 68:295–299

  5. 5.

    Garidou A, Tzonou A, Lipworth L, Signorello LB, Kalapothaki V, Trichopoulos D (1996) Diet and risk of esophageal cancer by histologic type in a low-risk population. Int J Cancer 68:300–304

  6. 6.

    Chatzopoulos D, Kyrgidis A, Kountouras J, Zavos C, Molyvas E, Venizelos I (2007) Bax upregulation may provide a rationale for the low incidence of esophageal adenocarcinoma in a Greek cohort of patients with Barrett’s esophagus. Hepatogastroenterology 54:705–709

  7. 7.

    Kyrgidis A, Kountouras J, Zavos C, Chatzopoulos D (2005) New molecular concepts of Barrett’s esophagus: clinical implications and biomarkers. J Surg Res 125:189–212

  8. 8.

    Kountouras J, Chatzopoulos D, Zavos C (2007) Eradication of Helicobacter pylori might halt the progress to oesophageal adenocarcinoma in patients with gastro-oesophageal reflux disease and Barrett’s oesophagus. Med Hypotheses 68:1174–1175

  9. 9.

    Kountouras J, Zavos C, Chatzopoulos D, Katsinelos P (2006) Helicobacter pylori and gastro-oesophageal reflux disease. Lancet 368:986

  10. 10.

    Kountouras J, Zavos C, Chatzopoulos D (2004) Induction of interleukin-8 expression by Helicobacter pylori infection in patients with endoscopy-negative gastroesophageal reflux disease. Am J Gastroenterol 99:2500–2501

  11. 11.

    Ferrández A, Benito R, Arenas J, García-González MA, Sopeña F, Alcedo J, Ortego J, Sainz R, Lanas A (2006) CagA-positive Helicobacter pylori infection is not associated with decreased risk of Barrett’s esophagus in a population with high H. pylori infection rate. BMC Gastroenterol 6:7

  12. 12.

    Schwizer W, Thumshirn M, Dent J, Guldenschuh I, Menne D, Cathomas G, Fried M (2001) Helicobacter pylori and symptomatic relapse of gastro-oesophageal reflux disease: a randomised controlled trial. Lancet 357:1738–1742

  13. 13.

    Liu FX, Wang WH, Wang J, Li J, Gao PP (2011) Effect of Helicobacter pylori infection on Barrett’s esophagus and esophageal adenocarcinoma formation in a rat model of chronic gastroesophageal reflux. Helicobacter 16:66–77

  14. 14.

    Kountouras J, Zavos C, Chatzopoulos D (2004) Risk of extra-oesophageal malignancies in Barrett’s oesophagus. Scand J Gastroenterol 39:1314

Download references

Conflict of interests

None declared.

Author information

Correspondence to Jannis Kountouras.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Kountouras, J., Chatzopoulos, D., Zavos, C. et al. Ki-67 and Bax expression in esophageal mucosa might have implications in ablative therapies for Barrett’s esophagus, dysplasia, and adenocarcinoma. Surg Endosc 26, 283–284 (2012). https://doi.org/10.1007/s00464-011-1864-1

Download citation

Keywords

  • Esophageal Cancer
  • Pylorus Infection
  • Gastroesophageal Reflux Disease
  • Pylorus Eradication
  • Esophageal Adenocarcinoma